These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21152908)

  • 21. Sex-differences in factors and outcomes associated with adherence to statin therapy in primary care: Need for customisation strategies.
    Olmastroni E; Boccalari MT; Tragni E; Rea F; Merlino L; Corrao G; Catapano AL; Casula M
    Pharmacol Res; 2020 May; 155():104514. PubMed ID: 31678211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poor Adherence to Statin and Antihypertensive Therapies as Risk Factors for Fatal Stroke.
    Herttua K; Martikainen P; Batty GD; Kivimäki M
    J Am Coll Cardiol; 2016 Apr; 67(13):1507-1515. PubMed ID: 27150680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to Prescribed Drugs Among 65-74 Year Old Men Diagnosed with Abdominal Aortic Aneurysm or Peripheral Arterial Disease in a Screening Trial: A VIVA Substudy.
    Qvist I; Søgaard R; Lindholt JS; Lorentzen V; Hallas J; Frost L
    Eur J Vasc Endovasc Surg; 2019 Mar; 57(3):442-450. PubMed ID: 30393062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications.
    Axon DR; Vaffis S; Chinthammit C; Lott BE; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989
    [No Abstract]   [Full Text] [Related]  

  • 25. Adherence to Triple-Free-Drug Combination Therapies Among Patients With Cardiovascular Disease.
    Lombardi N; Crescioli G; Simonetti M; Marconi E; Vannacci A; Bettiol A; Parretti D; Cricelli C; Lapi F
    Am J Cardiol; 2020 May; 125(9):1429-1435. PubMed ID: 32156412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM
    Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes.
    Xie G; Sun Y; Myint PK; Patel A; Yang X; Li M; Li X; Wu T; Li S; Gao R; Wu Y
    Lipids Health Dis; 2017 Aug; 16(1):155. PubMed ID: 28810873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-Associated Characteristics Influencing the Risk for Non-Persistence with Statins in Older Patients with Peripheral Arterial Disease.
    Wawruch M; Wimmer G; Murin J; Paduchova M; Tesar T; Hlinkova L; Slavkovsky P; Fabryova L; Aarnio E
    Drugs Aging; 2019 Sep; 36(9):863-873. PubMed ID: 31256366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of statin use and long-term adherence and persistence among older adults with diabetes.
    Ofori-Asenso R; Ilomäki J; Tacey M; Zomer E; Curtis AJ; Bell JS; Zoungas S; Liew D
    J Diabetes; 2018 Sep; 10(9):699-707. PubMed ID: 29658177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases.
    Corrao G; Scotti L; Zambon A; Baio G; Nicotra F; Conti V; Capri S; Tragni E; Merlino L; Catapano AL; Mancia G
    Atherosclerosis; 2011 Aug; 217(2):479-85. PubMed ID: 21592477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe.
    Rea F; Savaré L; Corrao G; Mancia G
    Adv Ther; 2021 Oct; 38(10):5270-5285. PubMed ID: 34480293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-statin adherence over 5 years of follow-up is associated with improved cardiovascular outcomes in patients with atherosclerotic cardiovascular disease: results from the IMPRES study.
    May HT; Knowlton KU; Anderson JL; Lappé DL; Bair TL; Muhlestein JB
    Eur Heart J Qual Care Clin Outcomes; 2022 May; 8(3):352-360. PubMed ID: 33787865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence to statins and its impact on clinical outcomes: a retrospective population-based study in China.
    Zhao B; He X; Wu J; Yan S
    BMC Cardiovasc Disord; 2020 Jun; 20(1):282. PubMed ID: 32522146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry.
    O'Brien EC; McCoy LA; Thomas L; Peterson ED; Wang TY
    Am Heart J; 2015 Jul; 170(1):55-61. PubMed ID: 26093864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term persistence with statin therapy: a nationwide register study in Finland.
    Helin-Salmivaara A; Lavikainen P; Korhonen MJ; Halava H; Junnila SY; Kettunen R; Neuvonen PJ; Martikainen JE; Ruokoniemi P; Saastamoinen LK; Virta L; Huupponen R
    Clin Ther; 2008; 30 Pt 2():2228-40. PubMed ID: 19281917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of two methods for estimating refill adherence to statins in Sweden: the RARE project.
    Lesén E; Sandström TZ; Carlsten A; Jönsson AK; Mårdby AC; Sundell KA
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1073-9. PubMed ID: 21853505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence--estimates from the Finnish prescription register.
    Aarnio E; Korhonen MJ; Huupponen R; Martikainen J
    Atherosclerosis; 2015 Mar; 239(1):240-7. PubMed ID: 25618032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does a cardiovascular event change adherence to statin treatment in patients with type 2 diabetes? A matched cohort design.
    de Vries FM; Denig P; Vegter S; Bos HJ; Postma MJ; Hak E
    Curr Med Res Opin; 2015 Apr; 31(4):595-602. PubMed ID: 25629791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.